Identification of DTYMK and CHEK1 as therapeutic targets in LKB1 mutant non-small cell lung cancer

被引：0
|
作者：
Liu, Yan [1 ]
Cowley, Glenn S. [2 ]
Cohoon, Travis J. [1 ]
Root, David E. [2 ]
Kwok-kin, Wong [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Broad Inst, Boston, MA USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-LB-260
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-260
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The Importance of STK11/LKB1 Assessment in Non-Small Cell Lung Carcinomas
    Mograbi, Baharia
    Heeke, Simon
    Hofman, Paul
    DIAGNOSTICS, 2021, 11 (02)
  • [32] LOSS OF LKB1 IS ASSOCIATED WITH RESISTANCE TO IFN-GAMMA AND T CELL KILLING IN NON-SMALL CELL LUNG CANCER
    Reuben, Alexandre
    Jiang, Peixin
    Nie, Hui
    Cobo, Ana Galan
    Dang, Minghao
    Qian, Yu
    Frank, Meredith
    Blitz, Emily
    Hamdi, Haifa
    Denning, Warren
    Nilsson, Monique
    Poteete, Alissa
    Shen, Li
    Wang, Qi
    Guijarro, Irene
    Nichols, Keri
    Khairullah, Roohussaba
    Zhang, Jiexin
    Skoulidis, Ferdinandos
    Wang, Jing
    Wang, Linghua
    Heymach, John
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A960 - A960
  • [33] Cell-of-origin links histotype spectrum to immune microenvironment diversity in non-small cell lung cancer driven by mutant Kras and loss of Lkb1
    Nagaraj, A.
    Lahtela, J.
    Hemmes, A.
    Mayranpaa, M.
    Salmenkivi, K.
    Narhi, K.
    Verschuren, E. W.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S89 - S89
  • [34] LKB1 gene inactivation does not sensitize non-small cell lung cancer cells to mTOR inhibitors in vitro
    Ping Xiao
    Lin-lin Sun
    Jing Wang
    Rui-li Han
    Qing Ma
    Dian-sheng Zhong
    Acta Pharmacologica Sinica, 2015, 36 : 1107 - 1112
  • [35] Inhibition of chemokine-induced myeloid cells potentiates the anti-PD-1 response in KRAS/LKB1 mutant non-small cell lung cancer
    Li, Rui
    Salehi-Rad, Ramin
    Momcilovic, Milica
    Ong, Stephanie
    Lim, Raymond
    Huang, Zi Ling
    Linh Tran
    Jing, Zhe
    Paul, Manash
    Teitell, Michael
    Minna, John
    Shackelford, David
    Kostyantyn, Krysan
    Liu, Bin
    Dubinett, Steven
    CANCER RESEARCH, 2020, 80 (16)
  • [36] LKB1/AMPK/mTOR Signaling Pathway in Non-small-cell Lung Cancer
    Han, Dong
    Li, Shao-Jun
    Zhu, Yan-Ting
    Liu, Lu
    Li, Man-Xiang
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (07) : 4033 - 4039
  • [37] Prognostic Impact of LKB1 Expression in Advanced Non-Small-Cell Lung Cancer
    Diaz-Garcia, D. A.
    Ramirez Tirado, L. A.
    Aviles-Salas, A.
    Cardona, A. F.
    Rodriguez-Rios, A.
    Barron, F.
    Arrieta, O. G.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S780 - S781
  • [38] A variant in LKB1 gene can predicts the clinical outcomes of chemotherapy in patients with non-small cell lung cancer
    Seo, Hyewon
    Kang, Hyo-Gyoung
    Jung, Deuk Kju
    Choi, Jin Eun
    Park, Hyeyoung
    Lee, Hyejin
    Oh, Hong Guen
    Lee, Young Hun
    Choi, Sun Ha
    Yoo, Seung Soo
    Lee, Shin Yup
    Lee, Jaehee
    Cha, Seung Ick
    Kim, Chang Ho
    Park, Jae Young
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [39] Expression of LKB1 tumor suppressor in non-small cell lung cancer determines sensitivity to 2-deoxyglucose
    Inge, Landon J.
    Coon, Keith D.
    Smith, Michael A.
    Bremner, Ross M.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 137 (03): : 580 - 586
  • [40] LKB1 gene inactivation does not sensitize non-small cell lung cancer cells to mTOR inhibitors in vitro
    Xiao, Ping
    Sun, Lin-lin
    Wang, Jing
    Han, Rui-li
    Ma, Qing
    Zhong, Dian-sheng
    ACTA PHARMACOLOGICA SINICA, 2015, 36 (09) : 1107 - 1112
12345